ICRF-187 and doxorubicin-induced cardiac toxicity.
D001943:Breast Neoplasms / Q000188:drug therapy; D002614:Chelating Agents / Q000627:therapeutic use*; D004317:Doxorubicin / Q000009:adverse effects*; D005260:Female; D006321:Heart / Q000187:drug effects*; D006801:Humans; D010879:Piperazines / Q000627:therapeutic use*; D011929:Razoxane / Q000627:therapeutic use*
D002614:Chelating Agents; D010879:Piperazines; D011929:Razoxane; D004317:Doxorubicin